Project Grant R16EB039695
- The National Institute of Biomedical Imaging and Bioengineering awarded Rensselaer Polytechnic Institute $366,006 on September 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a simulation-based inference framework that transforms functional near-infrared spectroscopy (fNIRS) data analysis through artificial intelligence. The project delivers a biophysically detailed simulator integrating realistic models...
- The National Institute of Biomedical Imaging and Bioengineering awarded the University of Rochester $226,625 on September 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a tandem-chip microphysiological system for assessing cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome in immunotherapy patients. The recipient will engineer an integrated drug development tool...
- The National Institute of Biomedical Imaging and Bioengineering awarded the University of Southern California $291,496 on July 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop high-resolution three-dimensional electrical impedance mapping technology for identifying metabolically active atherosclerotic plaques. The project develops a balloon-deployable catheter platform integrating ultrathin, highly...
- The National Institute of General Medical Sciences awarded the University of Rochester $399,475 on September 4, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop and validate photoacoustic stimulation as a tool for non-contact, label-free activation of the somatosensory system in cells and animals. The project develops a method in which pulsed light absorbed by tissue or dye sensitizers generates localized mechanical forces that activate ion channels,...
- The National Institute of Biomedical Imaging and Bioengineering awarded Wake Forest University $425,663 on August 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop skin-conformal, tissue-equivalent wearable dosimeter platforms for radiotherapy precision. The project, titled "Enhancing Radiotherapy Precision with Conformal, Tissue-Equivalent Dosimeters," addresses limitations in current clinical...
- The National Institute on Deafness and Other Communication Disorders awarded Rochester Institute of Technology $145,613 under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) on September 1, 2026. RIT will develop computational algorithms and a digital twin system to optimize phonosurgery outcomes by creating participant-specific models of vocal physiology and anatomy. The project integrates physics-informed deep learning, bi-fidelity computer modeling, and...
- The National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems awarded Rochester Institute of Technology $558,713 on February 1, 2026, under the Engineering program (CFDA 47.041) to study how human body movements affect blood flow dynamics within aneurysms. The project will employ a novel experimental platform integrating a robotic arm, a physically relevant aneurysm flow phantom, and particle image velocimetry to measure changes in aneurysm flow...
- The National Institute of Biomedical Imaging and Bioengineering awarded the Trustees of Boston University $232,550 on September 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a mid-infrared photothermal fiber probe for label-free imaging and biomolecular composition analysis in endoscopic applications. The project will develop a fiber-based probe that integrates mid-infrared photothermal imaging with...
- Rochester Institute of Technology (RIT) received a $248,480 Project Grant award from the National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems under the Engineering federal grant program (CFDA 47.041) to develop an interactive, data-enabled scientific computing platform for characterizing and monitoring cardiac tissue ablation. Through leveraging expertise in heat transfer theory, image computing, biomedical modeling and simulation, and...
- The National Institute of Biomedical Imaging and Bioengineering awarded Iowa State University of Science and Technology $215,723 on August 14, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a next-generation, handheld, battery-powered, wireless dual-mode ultrasound-photoacoustic imaging system integrating high-power nanosecond pulsed light-emitting diodes. The project addresses a gap in current imaging...
The National Institute of Biomedical Imaging and Bioengineering awarded Rochester Institute of Technology $179,227 on August 5, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop and validate skin phantoms for wearable hydration and bioimpedance sensors. RIT will design a multiparametric skin phantom spanning 0.1 Hz to 5 MHz with tunable porosity, controlled motion, perspiration, and evaporation to replicate human skin behavior across hydration states. The work comprises three aims: fully characterize the phantom's ability to mimic hydration, perspiration, and evaporation through porosity and environmental adjustment, producing a predictive impedance look-up table for reproducible electrode testing; develop layered structures that replicate deep-tissue impedance guided by finite-element modeling, tuning conductive and dielectric content to match human cadaver data within 5 percent; and validate the completed phantom against in-vivo human skin from thirty adults aged 18 to 85, with success defined as phantom impedance within 10 percent of averaged human data under static and motion conditions, including 10 percent cyclic strain at 0.5 Hz. The phantom addresses validation gaps in wearable health-monitoring devices by replacing empirical human or animal testing with a controlled, reproducible system that improves translation of sensor technologies. Place of performance is Rochester, New York. The period of performance runs through July 31, 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $179.2k | 8/4/26 |